Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients

Anh Pham; Ildiko Garai; Kovács Árpád; Ádám Dér; Erika Szanto; Zsolt Hascsi; Ferenc Bátyi; Ervin Berényi; Thong Minh Pham

doi:10.12659/MSM.942122

20 January 2024 : Clinical Research

Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients

Anh Pham^1ABDF*, Ildiko Garai^2ADE, Kovács Árpád^3A, Ádám Dér^3DE, Erika Szanto^3DE, Zsolt Hascsi^2A, Ferenc Bátyi^2B, Ervin Berényi^2A, Thong Minh Pham^1A

DOI: 10.12659/MSM.942122

Med Sci Monit 2024; 30:e942122

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 49 y/o patient with squamous cell carcinoma of the left nasal cavity and nasopharynx. Tumor target delineation using local threshold of 41% of the standard uptake volume (SUV) corrected for lean body mass (SULmax) of the lesion and absolute threshold of SUV2.5 was done on 18F-FDG PET/CT scan. Absolute threshold of SUV 2.5 delineation is seen on axial (A) coronal (B) and sagittal (C) fused PET/CT images with 270.5 ccm3.

Back to the Article

Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients

Your Privacy